Safety Information and Who Must Receive It

Part of Clinical Trial Assistant (CTA) Training: Safety Document Distribution.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Safety information exists to change what people do. A safety letter that is sent and not read has not worked, and the distribution record is the only evidence of whether it worked.

This is one of the few areas where a trial assistant's administrative task has a direct line to participant safety.

What gets distributed, and why

Expedited safety reports. Where a serious adverse reaction is both unexpected and suspected to be related to the product, it is reported to authorities on a clock and communicated to investigators. The common name in a US IND context is an IND safety letter; under Regulation (EU) 536/2014 the same underlying event is reported through a different mechanism. The obligation is the same; the instrument is regional.

Investigator's brochure updates. A new edition changes what is considered expected, which changes how future events are assessed. Receipt must be evidenced.

Urgent safety measures. Immediate action to protect participants, which may be taken before approval and must then be notified.

Aggregate reports such as the development safety update report, distributed on a cycle.

Who must receive it

All participating investigators, so they can assess whether their participants are affected and whether ongoing consent remains adequate. Ethics committees according to their own requirements, which vary. Regulatory authorities under the applicable national rule.

The list is per study and per jurisdiction. Do not carry it between studies from memory.

Distribution is not sending

The obligation is that the information reaches the people who must act on it. Three things follow.

Acknowledgement is the evidence. A sent-mail record shows you sent. It does not show receipt, and several sites will have staff changes, full mailboxes and spam filters.

Chase non-acknowledgement on a clock. Decide the interval in advance and apply it. Safety distribution is the wrong place for a soft touch.

File the whole cycle. The document, the distribution list, the date sent, the acknowledgements, and the chase record for anyone who did not respond.

The awkward case

Sooner or later a site will not acknowledge. Escalate rather than absorbing it. An unacknowledged safety letter at a site with active participants is a genuine issue, and the study's leadership needs it while they can still act.

The failure to avoid is a quiet one: marking distribution complete because the emails went out.

In practice

A safety letter arrives for distribution to 11 sites across 5 countries.

Before sending, four checks. The recipient list against current delegation, because two investigators have changed since the last distribution. The version, because a corrected letter sometimes follows a first issue within days. The required action, because this one asks sites to notify their ethics committees, which is a second tracked item. And translation, because two sites operate in a language the letter is not written in.

Sent individually, with an acknowledgement deadline of five working days stated in the message.

Day three. Eight acknowledged. Three have not.

Day five. Two remain. One is a site whose coordinator is on leave with no cover set. The other has not responded to anything for two weeks.

Day six. Both escalated to the study manager with the dates and the chase record. The first is resolved by contacting the investigator directly. The second turns out to be a site with a systems outage, and the letter is re-sent by an alternative route.

What the file holds afterwards

The letter, the distribution list with send dates, eight acknowledgements at first pass and two after escalation, the chase correspondence, the translations and their dates, and the ethics notifications each site made.

That set answers the inspector's actual question, which is never "did you send it" but "did everyone who needed this get it, when, and what did they do about it".

Key takeaways